<DOC>
	<DOCNO>NCT02777216</DOCNO>
	<brief_summary>To evaluate safety performance ConfidenHT System</brief_summary>
	<brief_title>ConfidenHT System Diagnostic Electrical Mapping Renal Nerves</brief_title>
	<detailed_description>To evaluate safety performance ConfidenHT System diagnostic mapping renal nerve ; functional distribution renal nerve effect renal nerve stimulation blood pressure</detailed_description>
	<criteria>1 . Signed write informed consent . 2 . Age &gt; 18 year &lt; 75 . 3 . Either : 1 . Hypertensive patient plan undergo elective cardiac catheterization 2 . Potential candidate renal sympathetic denervation 4 . Main renal artery diameter ≥ 4.0mm . 5 . Glomerular Filtration Rate ( GFR ) &gt; 45 mL/min 6 . A patient mentally competent ability understand comply requirement study . 7 . The patient agree attend followup evaluation willing complete require exams test . 8 . Female patient childbearing potential must agree : use valid method contraception ( oral contraceptive , intrauterine device , subcutaneous contraceptive implant , vaginal ring ) perform pregnancy test Exclusion criterion : 1 . Previous participation another study investigational drug device within past 30 day . 2 . Relevant renal artery disease ( % diameter stenosis &gt; 30 % , aneurysm fibromuscular dysplasia ) . 3 . Known secondary cause hypertension . 4 . The patient life expectancy ≤ 12 month . 5 . The patient undergone prior renal denervation , renal stenting , and/or abdominal aortic stent graft . 6 . The patient chronic oxygen use nocturnal support sleep apnea . 7 . The patient type I diabetes mellitus . 8 . The patient previous organ transplant await renal transplant . 9 . Active implantable medical device ( e.g . ICD CRTD ; neuromodulator/spinal stimulator ; baroreflex stimulator ) . 10 . The patient triple ipsilateral artery ostia . 11 . Moderate severe valvular heart disease . 12 . The patient concomitant condition may adversely affect patient study outcome . 13 . Female pregnant , nurse plan become pregnant . 14 . Documented contraindication allergy contrast medium amenable treatment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>RDN</keyword>
</DOC>